Thrombosis and Haemostasis challenges in COVID-19 – Therapeutic perspectives of heparin and tissue-type plasminogen activator and potential toxicological reactions-a mini review-Reference-Cited by-同舟云学术

Thrombosis and Haemostasis challenges in COVID-19 – Therapeutic perspectives of heparin and tissue-type plasminogen activator and potential toxicological reactions-a mini review

Published:2021-02 Issue: Volume:148 Page:111974
ISSN:0278-6915
Container-title:Food and Chemical Toxicology
language:en
Short-container-title:Food and Chemical Toxicology

Author:

Mazilu Laura^ORCID,Katsiki Niki,Nikolouzakis Taxiarchis Konstantinos^ORCID,Aslanidis Minas I.,Lazopoulos George,Kouretas Dimitrios,Tsatsakis Aristidis,Suceveanu Andra-Iulia,Stoian Anca-Pantea,Parepa Irinel-Raluca^ORCID,Voinea Felix,Suceveanu Adrian Paul,Arsene Andreea Letiția,Velescu Bruno Ștefan,Vesa Cosmin,Nitipir Cornelia

Funder

APS

Publisher

Elsevier BV

Subject

Toxicology,General Medicine,Food Science

Reference75 articles.

1. Streptokinase versus unfractionated heparin nebulization in patients with severe acute respiratory distress syndrome (ARDS): a randomized controlled trial with observational controls;Abdelaal Ahmed Mahmoud;J. Cardiothorac. Vasc. Anesth.,2020

2. Platelets at the interface of thrombosis, inflammation, and cancer

3. Inhalation therapies in acute respiratory distress syndrome;Artigas;Ann. Transl. Med.,2017

4. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up;Bikdeli;J. Am. Coll. Cardiol.,2020

5. Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?;Bodier-Montagutelli;Expet Opin. Drug Deliv.,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EFFECT OF LOW MOLECULAR WEIGHT HEPARIN IN THE PREVENTION OF SEVERE PNEUMONIA COMPLICATED WITH LOWER EXTREMITY DEEP VEIN THROMBOSIS;FARMACIA;2024

2. Causal Effects of COVID-19 on the Risk of Thrombosis: A Two-Sample Mendel Randomization Study;Thrombosis and Haemostasis;2024-02-07

3. Evaluation of various blood biomarkers associated with the outcomes of patients with COVID‑19 treated in intensive care units;Experimental and Therapeutic Medicine;2024-01-04

4. New-Onset Diabetes Mellitus in COVID-19: A Scoping Review;Diabetes Therapy;2023-09-26

5. Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19;Current Drug Targets;2022-12